We are a patient-centred biotechnology company developing novel medicinal products for use in infections or diseases associated with imbalances of bacteria in the human gut. We have established, staffed and integrated an ISO-accredited controlled donation facility and a fully equipped state-of-the-art manufacturing facility to manage collection, processing and formulation of medicinal products derived from healthy human donations.
We are focussed on developing first in class medicinal products for use in currently unmet clinical needs such as C.difficle infection. In parallel with this, we are using our niche platform to work with our collaborators to datasets from studies where the microbiome is being manipulated with the intention of identifying useful associations between microbial signatures and clinical response.
We believe that the microbiome is the next big frontier of medicine and our vision is simple: to work together to improve the lives of patients through sound science and pioneering medicines.
We are patient-centred in our quest to create value for our stakeholders and society, putting patients at the heart of everything we do.
We foster collaboration at every possible opportunity. As a company, EnteroBiotix does not work alone. We know that in order to achieve our mission we must form alliances and create partnerships.
We embrace innovation throughout our supply chain and product development. We look at our products as part of the overall patient experience, working in close partnership with our suppliers and healthcare providers to ensure we deliver the most effective therapies for patients and clinicians.
We believe in ownership at EnteroBiotix. We trust our employees and empower our staff to take full responsibility for their workload. In return, we provide flexible working arrangements and foster an inclusive, friendly working environment.